Buck Institute Launches AI-Powered Healthspan Initiative and Secures $34.5M ARPA-H Grant
Buck Institute unveils Healthspan Horizons AI platform and joins Stanford coalition to develop FDA-grade aging biomarkers.
Summary
The Buck Institute for Research on Aging announced two major initiatives in March 2026. Healthspan Horizons uses AI to integrate multi-modal health data for measuring and extending healthspan, making healthy aging more accessible. Separately, Buck joined a Stanford-led coalition securing up to $34.5 million from ARPA-H to develop the first FDA-grade 'Intrinsic Capacity Score' through the THRIVE project, which will use decentralized trials and YMCA interventions to extend healthspan.
Detailed Summary
The Buck Institute for Research on Aging made significant strides in longevity research with two groundbreaking announcements in March 2026. These initiatives represent major advances in making aging science more measurable and clinically applicable.
The first initiative, Healthspan Horizons, launched on March 5, 2026, creates long-term datasets using artificial intelligence to measure, understand, and extend healthspan. Led by Buck President Eric Verdin and Professor Nathan Price, this platform integrates multi-modal health data responsibly, aiming to make healthy aging both measurable and accessible to broader populations.
Simultaneously, Buck Institute joined a Stanford-led coalition that secured up to $34.5 million in funding from ARPA-H through the THRIVE project. This ambitious initiative aims to develop the first FDA-grade 'Intrinsic Capacity Score' - a comprehensive biomarker system for aging. Buck researchers David Furman and Brianna Stubbs emphasized the project's innovative approach using decentralized trials and community-based interventions through YMCA partnerships.
These developments mark a pivotal shift toward standardized, AI-driven approaches to longevity research. The combination of advanced data integration and community-based implementation could democratize access to healthspan optimization tools. Both initiatives focus on translating complex aging science into practical, measurable interventions that can be deployed at scale, potentially revolutionizing how we approach healthy aging in clinical and community settings.
Key Findings
- Healthspan Horizons uses AI to integrate multi-modal health data for measuring healthspan
- THRIVE project develops first FDA-grade 'Intrinsic Capacity Score' for aging assessment
- Buck Institute secured up to $34.5M ARPA-H funding through Stanford coalition
- Decentralized trials and YMCA partnerships will test community-based interventions
- Both initiatives aim to make healthy aging measurable and accessible
Methodology
Healthspan Horizons employs AI-driven integration of multi-modal health datasets to create long-term aging measurements. The THRIVE project utilizes decentralized trial designs with community-based interventions through YMCA partnerships to develop and validate FDA-grade aging biomarkers.
Study Limitations
This summary is based on press release abstracts only, lacking detailed methodology and preliminary results. The initiatives are newly announced without published data on effectiveness or validation of the proposed biomarkers and interventions.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.